203 related articles for article (PubMed ID: 29756345)
1. Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition.
Kharasch ED; Crafford A
Clin Pharmacol Ther; 2019 Jan; 105(1):142-152. PubMed ID: 29756345
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic Influence on Stereoselective Steady-State Disposition of Bupropion.
Kharasch ED; Lenze EJ
Drug Metab Dispos; 2024 Apr; 52(5):455-466. PubMed ID: 38467432
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective Bupropion Hydroxylation by Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase Genetic Variants.
Wang PF; Neiner A; Kharasch ED
Drug Metab Dispos; 2020 Jun; 48(6):438-445. PubMed ID: 32238417
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity.
Kharasch ED; Mitchell D; Coles R
J Clin Pharmacol; 2008 Apr; 48(4):464-74. PubMed ID: 18287571
[TBL] [Abstract][Full Text] [Related]
5. The P450 oxidoreductase (POR) rs2868177 and cytochrome P450 (CYP) 2B6*6 polymorphisms contribute to the interindividual variability in human CYP2B6 activity.
Gao LC; Liu FQ; Yang L; Cheng L; Dai HY; Tao R; Cao SP; Wang D; Tang J
Eur J Clin Pharmacol; 2016 Oct; 72(10):1205-1213. PubMed ID: 27439448
[TBL] [Abstract][Full Text] [Related]
6. Effects of the selected cytochrome P450 oxidoreductase genetic polymorphisms on cytochrome P450 2B6 activity as measured by bupropion hydroxylation.
Lv J; Hu L; Zhuo W; Zhang C; Zhou H; Fan L
Pharmacogenet Genomics; 2016 Feb; 26(2):80-7. PubMed ID: 26580670
[TBL] [Abstract][Full Text] [Related]
7. Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6.
Kirchheiner J; Klein C; Meineke I; Sasse J; Zanger UM; Mürdter TE; Roots I; Brockmöller J
Pharmacogenetics; 2003 Oct; 13(10):619-26. PubMed ID: 14515060
[TBL] [Abstract][Full Text] [Related]
8. Effect of CYP2B6*6 on Steady-State Serum Concentrations of Bupropion and Hydroxybupropion in Psychiatric Patients: A Study Based on Therapeutic Drug Monitoring Data.
Høiseth G; Haslemo T; Uthus LH; Molden E
Ther Drug Monit; 2015 Oct; 37(5):589-93. PubMed ID: 25565674
[TBL] [Abstract][Full Text] [Related]
9. Nonresponse to high-dose bupropion for depression in a patient carrying
Stäuble CK; Lampert ML; Mikoteit T; Hatzinger M; Hersberger KE; Meyer Zu Schwabedissen HE
Pharmacogenomics; 2020 Nov; 21(16):1145-1150. PubMed ID: 33124517
[TBL] [Abstract][Full Text] [Related]
10. Efavirenz induces CYP2B6-mediated hydroxylation of bupropion in healthy subjects.
Robertson SM; Maldarelli F; Natarajan V; Formentini E; Alfaro RM; Penzak SR
J Acquir Immune Defic Syndr; 2008 Dec; 49(5):513-9. PubMed ID: 18989234
[TBL] [Abstract][Full Text] [Related]
11. Chirality and neuropsychiatric drugs: an update on stereoselective disposition and clinical pharmacokinetics of bupropion.
Dash RP; Rais R; Srinivas NR
Xenobiotica; 2018 Sep; 48(9):945-957. PubMed ID: 28876959
[TBL] [Abstract][Full Text] [Related]
12. Genetic Variants of Pregnane X Receptor (PXR) and CYP2B6 Affect the Induction of Bupropion Hydroxylation by Sodium Ferulate.
Gao L; He Y; Tang J; Yin J; Huang Z; Liu F; Ouyang D; Chen X; Zhang W; Liu Z; Zhou H
PLoS One; 2013; 8(6):e62489. PubMed ID: 23840296
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe Substrate.
Mohamed MF; Minocha M; Trueman S; Feng T; Enejosa J; Fisniku O; Othman AA
Clin Pharmacol Drug Dev; 2021 Mar; 10(3):299-306. PubMed ID: 32648334
[TBL] [Abstract][Full Text] [Related]
14. Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects.
Kim H; Bae SK; Park SJ; Shim EJ; Kim HS; Shon JH; Liu KH; Shin JG
Br J Clin Pharmacol; 2010 Jul; 70(1):126-31. PubMed ID: 20642555
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective metabolism of bupropion by cytochrome P4502B6 (CYP2B6) and human liver microsomes.
Coles R; Kharasch ED
Pharm Res; 2008 Jun; 25(6):1405-11. PubMed ID: 18219560
[TBL] [Abstract][Full Text] [Related]
16. Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation.
Fan L; Wang JC; Jiang F; Tan ZR; Chen Y; Li Q; Zhang W; Wang G; Lei HP; Hu DL; Wang D; Zhou HH
Eur J Clin Pharmacol; 2009 Apr; 65(4):403-9. PubMed ID: 19066872
[TBL] [Abstract][Full Text] [Related]
17. Subtherapeutic bupropion and hydroxybupropion serum concentrations in a patient with CYP2C19*1/*17 genotype suggesting a rapid metabolizer status.
Gaebler AJ; Schneider KL; Stingl JC; Paulzen M
Pharmacogenomics J; 2020 Dec; 20(6):840-844. PubMed ID: 32475982
[TBL] [Abstract][Full Text] [Related]
18. Effects of Genetic Polymorphisms of CYP2B6 on the Pharmacokinetics of Bupropion and Hydroxybupropion in Healthy Chinese Subjects.
Ma H; Zhang W; Yang X; Zhang Y; Wei S; Zhang H; Ma Y; Dang H
Med Sci Monit; 2018 Apr; 24():2158-2163. PubMed ID: 29637923
[TBL] [Abstract][Full Text] [Related]
19. The influence of sex, ethnicity, and CYP2B6 genotype on bupropion metabolism as an index of hepatic CYP2B6 activity in humans.
Ilic K; Hawke RL; Thirumaran RK; Schuetz EG; Hull JH; Kashuba AD; Stewart PW; Lindley CM; Chen ML
Drug Metab Dispos; 2013 Mar; 41(3):575-81. PubMed ID: 23238783
[TBL] [Abstract][Full Text] [Related]
20. Rapid clinical induction of bupropion hydroxylation by metamizole in healthy Chinese men.
Qin WJ; Zhang W; Liu ZQ; Chen XP; Tan ZR; Hu DL; Wang D; Fan L; Zhou HH
Br J Clin Pharmacol; 2012 Dec; 74(6):999-1004. PubMed ID: 22519658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]